Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: A french multicenter study

Autoimmunity Reviews

Volumn 13, Issue 10, 2014, Pages 1035-1041

  Néel, Antoine ^a   Henry, Benoit ^a   Barbarot, Sebastien ^a   Masseau, Agathe ^a   Perrin, François ^a   Bernier, Claire ^a   Kyndt, Xavier ^b   Puechal, Xavier ^c   Weiller, Pierre Jean ^d   Decaux, Olivier ^e,f   Ninet, Jacques ^g   Hot, Arnaud ^g   Aouba, Achille ^h   Astudillo, Leonardo ⁱ   Berthelot, Jean Marie ^a   Bonnet, Fabrice ^j   Brisseau, Jean Marie ^a   Cador, Bérangère ^e   Closs Prophette, Fabienne ^k   Dejoie, Thomas ^a   de Korwin, Jean Dominique ^l   Dhote, Robin ^m   Fior, Renato ^h   Grosbois, Bernard ^e,f   Hachulla, Eric ^n,o,p   Hatron, Pierre Yves ^n,o   Jardel, Henry ^q   Launay, David ^n,o,p   Lorleac'h, Adrien ^r   Pottier, Pierre ^a,s   Moulis, Guillaume ^t   Serratrice, Jacques ^d   Smail, Amar ^t   Hamidou, Mohamed ^a,s   more..

^a NANTES UNIVERSITY HOSPITAL   (France)

^b CENTRE HOSPITALIER DE VALENCIENNES   (France)

^c Service de Médecine Interne Néphrologie ^*  (France)

^d TIMONE HOSPITAL   (France)

^e RENNES UNIVERSITY HOSPITAL   (France)

^f UNIVERSITÉ DE RENNES 1   (France)

^g EDOUARD HERRIOT HOSPITAL   (France)

^h HÔPITAL ANTOINE BÉCLÈRE   (France)

ⁱ TOULOUSE UNIVERSITY HOSPITAL   (France)

^j BORDEAUX UNIVERSITY HOSPITAL   (France)

^k CENTRE HOSPITALIER DU MANS   (France)

^l UNIVERSITY HOSPITAL OF NANCY   (France)

^m AVICENNE HOSPITAL   (France)

ⁿ LILLE UNIVERSITY HOSPITAL   (France)

^o UNIV LILLE   (France)

^p IFR 114   (France)

^q CH Bretagne Atlantique   (France)

^r Service de Médecine Interne et Maladies Infectieuses   (France)

^s UNIVERSITÉ DE NANTES   (France)

^t AMIENS UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Autoinflammatory disease; Gammopathy; IL 1 receptor antagonist; Schnitzler's syndrome; Urticaria

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN M; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; AGED; ANEMIA; ARTHRALGIA; BONE LESION; BONE PAIN; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; DRUG TREATMENT FAILURE; FEMALE; FEVER; FRANCE; HUMAN; INFECTION; INJECTION SITE REACTION; KIDNEY AMYLOIDOSIS; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTICENTER STUDY (TOPIC); NEUTROPENIA; PNEUMONIA; QUALITY OF LIFE; REVIEW; SCHNITZLER SYNDROME; SORE THROAT; TREATMENT OUTCOME; URTICARIA; WALDENSTROEM MACROGLOBULINEMIA; WEIGHT REDUCTION; CLINICAL TRIAL; MULTICENTER STUDY; REMISSION; RETROSPECTIVE STUDY;

FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; QUALITY OF LIFE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SCHNITZLER SYNDROME;

EID: 84908146365     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.08.031     Document Type: Review

References (39)

1. Lipsker D. The Schnitzler syndrome. Orphanet J Rare Dis 2010, 5:38.
2. Simon A., Asli B., Braun-Falco M., De Koning H., Fermand J.P., Grattan C., et al. Schnitzler's syndrome: diagnosis, treatment, and follow-up. Allergy 2013, 68:562-568.
3. Schnitzler L., Schubert B., Boasson M., Gardais J., Tourmen A. Urticaire chronique, lésions osseuses, macroglobulinémie IgM: maladie de Waldenström. Bull Soc Fr Dermatol Syphiligr 1974, 81:363.
4. Schnitzler L., Hurez D., Verret J.L. Urticaire chronique-osteocodensation-macroglobulinemie. Cas princeps. Etude sur 20 ans. Ann Dermatol Venereol 1989, 116:547-550.
5. Jain T., Offord C.P., Kyle R., Dingli D. Schnitzler syndrome-an under diagnosed clinical entity. Haematologica 2013, 98:1581-1585.
6. Claes K., Bammens B., Delforge M., Evenepoel P., Kuypers D., Vanrenterghem Y. Another devastating complication of the Schnitzler syndrome: AA amyloidosis. Br J Dermatol 2008, 158:182-184.
7. de Koning H.D., Bodar E.J., van der Meer J.W., Simon A. Schnitzler Syndrome Study Group. Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum 2007, 37:137-148.
8. Martinez-Taboada V.M., Fontalba A., Blanco R., Fernández-Luna J.L. Successful treatment of refractory Schnitzler syndrome with anakinra: comment on the article by Hawkins et al. Arthritis Rheum 2005, 52:2226-2227.
9. Gran J.T., Midtvedt Ø., Haug S., Aukrust P. Treatment of Schnitzler's syndrome with anakinra: report of three cases and review of the literature. Scand J Rheumatol 2011, 40:74-79.
10. de Koning H.D., Schalkwijk J., van der Ven-Jongekrijg J., Stoffels M., van der Meer J.W., Simon A. Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome. Ann Rheum Dis 2013, 72:1634-1638.
11. Krause K., Weller K., Stefaniak R., Wittkowski H., Altrichter S., Siebenhaar F., et al. Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study. Allergy 2012, 67:943-950.
12. Ryan J.G., de Koning H.D., Beck L.A., Booty M.G., Kastner D.L., Simon A. IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission. J Allergy Clin Immunol 2008, 121:260-262.
13. Pizzirani C., Falzoni S., Govoni M., La Corte R., Donadei S., Di Virgilio F., et al. Dysfunctional inflammasome in Schnitzler's syndrome. Rheumatology (Oxford) 2009, 48:1304-1308.
14. Migliorini P., Del Corso I., Tommasi C., Boraschi D. Free circulating interleukin-18 is increased in Schnitzler syndrome: a new autoinflammatory disease?. Eur Cytokine Netw 2009, 20:108-111.
15. Launay D., Dutoit-Lefevre V., Faure E., Robineau O., Hauspie C., Sobanski V., et al. Effect of in vitro and in vivo anakinra on cytokines production in Schnitzler syndrome. PLoS One 2013, 8:e59327.
16. Tinazzi E., Puccetti A., Patuzzo G., Sorleto M., Barbieri A., Lunardi C. Schnitzler syndrome, an autoimmune-autoinflammatory syndrome: report of two new cases and review of the literature. Autoimmun Rev 2011, 10:404-409.
17. Krause K., Feist E., Fiene M., Kallinich T., Maurer M. Complete remission in 3 of 3 anti-IL-6-treated patients with Schnitzler syndrome. J Allergy Clin Immunol 2012, 129:848-850.
18. Sokumbi O., Drage L.A., Peters M.S. Clinical and histopathologic review of Schnitzler syndrome: the Mayo Clinic experience (1972-2011). J Am Acad Dermatol 2012, 67:1289-1295.
19. Lipsker D., Veran Y., Grunenberger F., Cribier B., Heid E., Grosshans E. The Schnitzler syndrome. Four new cases and review of the literature. Medicine (Baltimore) 2001, 80:37-44.
20. Asli B., Bienvenu B., Cordoliani F., Brouet J.C., Uzunhan Y., Arnulf B., et al. Chronic urticaria and monoclonal IgM gammopathy (Schnitzler syndrome): report of 11 cases treated with pefloxacin. Arch Dermatol 2007, 143:1046-1050.
21. Terpos E., Asli B., Christoulas D., Brouet J.C., Kastritis E., Rybojad M., et al. Increased angiogenesis and enhanced bone formation in patients with IgM monoclonal gammopathy and urticarial skin rash: new insight into the biology of Schnitzler syndrome. Haematologica 2012, 97:1699-1703.
22. Longhurst H.J., Yong P.F., Manson A.L., Cavenagh J.D., Grigoriadou S., Buckland M.S. Mullins' syndrome: a new gammopathy-related autoinflammatory syndrome resistant to anakinra. QJM 2012, [Epub Oct 29]. 10.1093/qjmed/hcs208.
23. Lee K.Y., Grattan C.E. Intracostal neuralgia as a previously undescribed symptom of Schnitzler's syndrome. Br J Dermatol 2012, 167:1392-1393.
24. Volz T., Wölbing F., Fischer J., Braun M., Maggoschitz I., Schaller M., et al. Dermal interleukin-1 expression and effective and long-lasting therapy with interleukin-1 receptor antagonist anakinra in Schnitzler syndrome. Acta Derm Venereol 2012, 92:393-394.
25. Larocca C.A., McEvoy J.W., Ellis C.L., Junkins-Hopkins J., Kolb T., Baer A.N., et al. Schnitzler's syndrome associated with pancreatitis: a disease of IL-1 dysregulation. Clin Rheumatol 2012, 31:169-174.
26. Sedivá A., Poloučková A., Podrazil M., Froňková E., Kalina T. Characterization of the B-cell compartment in a patient with Schnitzler syndrome. Scand J Rheumatol 2011, 40:158-160.
27. Szturz P., Adam Z., Hájek R., Mayer J. Successful anakinra therapy in 2 patients with Schnitzler syndrome. Onkologie 2011, 34:265-268.
28. Nuki G., Bresnihan B., Bear M.B., McCabe D. European Group Of Clinical Investigators. Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2002, 46:2838-2846.
29. Giampietro C., Ridene M., Lequerre T., Costedoat Chalumeau N., Amoura Z., Sellam J., et al. Anakinra in adult-onset Still's disease: long-term treatment in patients resistant to conventional therapy. Arthritis Care Res (Hoboken) 2013, 65:822-826.
30. Gerfaud-Valentin M., Jamilloux Y., Iwaz J., Sève P. Adult-onset Still's disease. Autoimmun Rev 2014, 13:708-722.
31. Laskari K., Tzioufas A.G., Moutsopoulos H.M. Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study. Arthritis Res Ther 2011, 13:R91.
32. Caorsi R., Federici S., Gattorno M. Biologic drugs in autoinflammatory syndromes. Autoimmun Rev 2012, 12:81-86.
33. Saadoun D., Bodaghi B., Bienvenu B., Wechsler B., Sene D., Trad S., et al. Biotherapies in inflammatory ocular disorders: Interferons, immunoglobulins, monoclonal antibodies. Autoimmun Rev 2013, 12:774-783.
34. Maestroni S., Di Corato P.R., Cumetti D., Chiara D.B., Ghidoni S., Prisacaru L., et al. Recurrent pericarditis: autoimmune or autoinflammatory?. Autoimmun Rev 2012, 12:60-65.
35. Ghogomu E., Tugwell P. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database Syst Rev 2009, 4:CD007848.
36. Singh J.A., Wells G.A., Christensen R., Tanjong Ghogomu E., Maxwell L., Macdonald J.K., et al. Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev 2011, 2:CD008794.
37. Verret J.L., Leclech C., Rousselet M.C., Hurez D., Schnitzler L. Schnitzler syndrome and Waldenström's disease. Fatal outcome of the original case. Ann Dermatol Venereol 1993, 120:459-460.
38. Obici L., Merlini G. Amyloidosis in autoinflammatory syndromes. Autoimmun Rev 2012, 12:14-17.
39. Koné-Paut I., Piram M. Targeting interleukin-1β in CAPS (cryopyrin-associated periodic) syndromes: what did we learn?. Autoimmun Rev 2012, 12:77-80.